Potential Application of the National Kidney Foundation's Chronic Kidney Disease Guidelines in a Managed Care SettingByMicah L. Thorp, DO, MPH,Loris Eastman, RN, CNNJuly 1st 2004
Genetic Testing and Pharmacogenomics: Issues for Determining the Impact to Healthcare Delivery and CostsByKathryn A. Phillips, PhD,David L. Veenstra, PharmD, PhD,Scott D. Ramsey, MD, PhD,Stephanie L. Van Bebber, MSc,Julie Sakowski, PhDJuly 1st 2004
Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step TherapyByBrenda R. Motheral, PhD,Rochelle Henderson, MPA,Emily R. Cox, PhDJuly 1st 2004
Prescribing Proton Pump Inhibitors for Initial Treatment of Acid-related Gastrointestinal Diseases in a Managed Care PopulationByJames Chan, PharmD, PhD,Rita L. Hui, PharmD, MS,Jean-Luc Szpakowski, MDJuly 1st 2004
Using Guidelines to Improve Care of Patients With Chronic Kidney DiseaseByTheodore I. Steinman, MDJuly 1st 2004
